Division of Hematology and Oncology Archive — Page 15 of 16

Illustration of red blood cells and several white blood cells suspended in a red bloodstream.
July 13, 2015

Hhex on cancer

A new mouse model demonstrates that the Hhex gene – which is linked to blood cancers – is critical for normal blood cell production.

Illustration of overlapping purple spherical cells, each with a prominent blue spherical nucleus, against a black background.
March 12, 2015

Gene mutations may predict melanoma response to immunotherapies

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators.

Deciphering DNA code
November 20, 2014

Gene mutation linked to breast cancer therapy resistance

A group of Vanderbilt-led investigators has identified a new gene mutation that may explain why some breast cancer patients do not respond to anti-hormone therapy.

Close-up of a person wearing a pink polo shirt with a pink awareness ribbon pinned to the chest.
October 23, 2014

VICC investigators earn breast cancer grants

The grants, which total $830,000, are part of the non-profit organization’s commitment to young scientists, as well as established investigators who are searching for more effective breast cancer therapies.

Stylized blue lungs on a dark background, with the right lung breaking apart into floating geometric fragments.
September 4, 2014

Lung cancer study reveals new drug combination targets

A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways.

Two researchers in white lab coats stand side by side in a laboratory, with shelves of bottles, containers, and equipment behind them.
July 31, 2014

VICC investigators land Komen breast cancer research grants

Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation.